ORIC Pharmaceuticals Inc.

NASDAQ: ORIC · Real-Time Price · USD
9.11
0.03 (0.33%)
At close: Jun 05, 2025, 3:59 PM
9.15
0.44%
After-hours: Jun 05, 2025, 07:52 PM EDT
0.33%
Bid 8.04
Market Cap 647.61M
Revenue (ttm) 533K
Net Income (ttm) -132.86M
EPS (ttm) -1.88
PE Ratio (ttm) -4.85
Forward PE -5.23
Analyst Buy
Ask 9.5
Volume 1,290,964
Avg. Volume (20D) 1,109,036
Open 8.99
Previous Close 9.08
Day's Range 8.85 - 9.46
52-Week Range 3.90 - 14.67
Beta 1.48

About ORIC

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ORIC
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ORIC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 week ago
+33.5%
Oric Pharmaceuticals shares are trading higher aft... Unlock content with Pro Subscription
1 week ago
+3.29%
ORIC Pharmaceuticals shares are trading higher after the company announced preliminary efficacy and safety data from its ongoing Phase 1b trial of ORIC-944. Additionally, the company announced a $125 million private placement, which was priced at an 18% premium to its 10-day trailing volume-weighted average price.